VGS is a revenue stage company located in Tel Aviv, Israel. VGS developed novel external scaffolds for the treatment of the Achilles hill of peripheral and heart bypass surgeries (CABG) – vein graft disease. The company’s products are commercialized in several European markets and used routinely in leading heart and vascular centers.